The off-label use of ketamine for treatment-resistant depression and other mental disorders has expanded rapidly in the past five years, offering many patients hope. However, recently published data suggest that a lack of safeguards ensuring safe ketamine therapy—coupled with meager implementation of guidelines—means pregnant women are at risk of exposing their fetuses to the potentially harmful drug.
“Risks of fetal ketamine exposure are often overlooked, indicating a need for
To read the full story, Register or Login
Register / Login
Illinois approves 4 new conditions for women for medical marijuana
Marijuana plants grow in an Illinois cultivation facility in 2023.
